La Chaux-de-Fonds, Switzerland

Swaroop Kumar Venkata Satya Vakkalanka

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Swaroop Kumar Venkata Satya Vakkalanka: Innovator in Kinase Inhibitors

Introduction

Swaroop Kumar Venkata Satya Vakkalanka is a notable inventor based in La Chaux-de-Fonds, Switzerland. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 2 patents, his work focuses on innovative solutions for treating kinase-mediated diseases.

Latest Patents

His latest patents include "Purine derivatives as SIK-3 inhibitors," which relates to novel inhibitors of salt-inducible kinase-3 (SIK3). This invention encompasses methods of preparing these inhibitors, pharmaceutical compositions containing them, and methods for the treatment and/or prevention of kinase-mediated diseases or disorders. Another significant patent is "PI3K protein kinase inhibitors," which provides novel compounds useful as PI3K protein kinase modulators, specifically targeting PI3K delta (δ) and/or gamma (γ) protein kinase modulators. This disclosure also includes methods for preparing these modulators and their applications in treating PI3K kinase-mediated diseases.

Career Highlights

Swaroop Kumar Venkata Satya Vakkalanka is currently associated with Rhizen Pharmaceuticals AG, where he continues to advance his research and development efforts in the pharmaceutical industry. His work is characterized by a commitment to innovation and the pursuit of effective treatments for complex diseases.

Collaborations

He collaborates with esteemed colleagues such as Prashant Kashinath Bhavar and Govindarajulu Babu, contributing to a dynamic research environment that fosters creativity and scientific advancement.

Conclusion

Swaroop Kumar Venkata Satya Vakkalanka exemplifies the spirit of innovation in the pharmaceutical field, with his patents paving the way for new therapeutic options. His contributions are vital in the ongoing battle against kinase-mediated diseases, showcasing the importance of research and collaboration in the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…